Colchicine After Electrocardioversion for Atrial Fibrillation

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 416 participants.

Also called NCT05890664

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 416 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05890664
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Switzerland (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05890664. Randomized; triple masking; primary purpose treatment. Start 2024-04-14 (actual); primary completion 2027-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Colchicine After Electrocardioversion for Atrial Fibrillation
Acronym
COLECTRO-AF
Condition
Cardiac Arrhythmia
Intervention (Drug)
Colchicine
Intervention (Drug)
Placebo
Lead sponsor
University Hospital, Basel, Switzerland (class: other)
Collaborator
Swiss Heart Foundation (class: other)
Collaborator
Fondation Machaon, Switzerland, Genf (class: not stated)
Collaborator
Foundation for Cardiovascular Research Basel (class: not stated)

Record details

Record id
cardio:ct-nct05890664
Content hash
537c02d7c4a69dbf20e3b5e4649238786cc05b5d4078acd53bab7120b0482743